Ident. | Authors (with country if any) | Title |
---|
002628 |
Quirine Fillekes [Royaume-Uni] ; Veronica Mulenga ; Desiré Kabamba ; Chipepo Kankasa ; Margaret J. Thomason ; Adrian Cook ; Chifumbe Chintu ; Diana M. Gibb ; A Sarah Walker ; David M. Burger | Is nevirapine dose-escalation appropriate in young, African, HIV-infected children? |
003A16 |
Quirine Fillekes [Pays-Bas] ; Veronica Mulenga [Zambie] ; Desire Kabamba [Zambie] ; Chipepo Kankasa [Zambie] ; Margaret J. Thomason [Royaume-Uni] ; Adrian Cook [Royaume-Uni] ; Alex Ferrier [Royaume-Uni] ; Chifumbe Chintu [Zambie] ; A. Sarah Walker [Royaume-Uni] ; Diana M. Gibb [Royaume-Uni] ; David M. Burger [Pays-Bas, Zambie] | Pharmacokinetics of nevirapine in HIV-infected infants weighing 3 kg to less than 6 kg taking paediatric fixed dose combination tablets |
003D71 |
Jessica E. Haberer [États-Unis] ; Adrian Cook [Royaume-Uni] ; A. Sarah Walker [Royaume-Uni] ; Marjorie Ngambi [Zambie] ; Alex Ferrier [Royaume-Uni] ; Veronica Mulenga [Zambie] ; Cissy Kityo [Ouganda] ; Margaret Thomason [Royaume-Uni] ; Desiree Kabamba [Zambie] ; Chifumbe Chintu [Zambie] ; Diana M. Gibb [Royaume-Uni] ; David R. Bangsberg [États-Unis] | Excellent Adherence to Antiretrovirals in HIV+ Zambian Children Is Compromised by Disrupted Routine, HIV Nondisclosure, and Paradoxical Income Effects |
004382 |
Andrew J. Nunn [Royaume-Uni, Zambie] ; Peter B. Mwaba [Zambie, Royaume-Uni] ; Chifumbe Chintu [Zambie, Royaume-Uni] ; Angela M. Crook [Royaume-Uni, Zambie] ; Janet H. Darbyshire [Royaume-Uni, Zambie] ; Yusuf Ahmed [Zambie, Royaume-Uni] ; Alimuddin I. Zumla [Zambie, Royaume-Uni] | Randomised, placebo-controlled trial to evaluate co-trimoxazole to reduce mortality and morbidity in HIV-infected post-natal women in Zambia (TOPAZ) |
006321 |
Mairin Ryan [Irlande (pays)] ; Susan Griffin [Royaume-Uni] ; Bona Chitah [Zambie] ; A. Sarah Walker [Royaume-Uni] ; Veronica Mulenga [Zambie] ; Donald Kalolo [Zambie] ; Neil Hawkins [Royaume-Uni] ; Concepta Merry [Irlande (pays)] ; Michael G. Barry [Irlande (pays)] ; Chifumbe Chintu [Zambie] ; Mark J. Sculpher [Royaume-Uni] ; Diana M. Gibb [Royaume-Uni] | The cost-effectiveness of cotrimoxazole prophylaxis in HIV-infected children in Zambia |
006C81 |
A. Sarah Walker [Royaume-Uni] ; Veronica Mulenga [Zambie] ; Deborah Ford [Royaume-Uni] ; Desire Kabamba [Zambie] ; Frederick Sinyinza [Zambie] ; Chipepo Kankasa [Zambie] ; Chifumbe Chintu [Zambie] ; Diana M. Gibb [Royaume-Uni] | The Impact of Daily Cotrimoxazole Prophylaxis and Antiretroviral Therapy on Mortality and Hospital Admissions in HIV-Infected Zambian Children |
006C96 |
Jane C. Ellis [Malawi] ; Rafaëlla F. A. L'Homme [Pays-Bas] ; Fiona M. Ewings [Royaume-Uni] ; Veronica Mulenga [Zambie] ; Frank Bell [Malawi] ; Regina Chileshe [Zambie] ; Elizabeth Molyneux [Malawi] ; Julia Abernethy [Royaume-Uni] ; Joep J. G. Van Oosterhout [Malawi] ; Chifumbe Chintu [Zambie] ; A Sarah Walker [Royaume-Uni] ; Diana M. Gibb [Royaume-Uni] ; David M. Burger [Pays-Bas] | Nevirapine concentrations in HIV-infected children treated with divided fixed-dose combination antiretroviral tablets in Malawi and Zambia |
006D15 |
Veronica Mulenga [Zambie] ; Deborah Ford [Royaume-Uni] ; A. Sarah Walker [Royaume-Uni] ; Darlington Mwenya [Zambie] ; James Mwansa [Zambie] ; Frederick Sinyinza [Zambie] ; Kennedy Lishimpi [Zambie] ; Andrew Nunn [Royaume-Uni] ; Stephen Gillespie [Royaume-Uni] ; Ali Zumla [Royaume-Uni] ; Chifumbe Chintu [Zambie] ; Diana M. Gibb [Royaume-Uni] | Effect of cotrimoxazole on causes of death, hospital admissions and antibiotic use in HIV-infected children |
008615 |
Chifumbe Chintu [Zambie] ; Victor Mudenda [Zambie] ; Sebastian Lucas [Royaume-Uni] ; Andrew Nunn [Zambie, Royaume-Uni] ; Kennedy Lishimpi [Zambie] ; Daniel Maswahu [Zambie, Royaume-Uni] ; Francis Kasolo [Zambie] ; Peter Mwaba [Zambie] ; Ganapati Bhat [Zambie] ; Hiroshi Terunuma [Zambie] ; Alimuddin Zumla [Zambie, Royaume-Uni] | Lung diseases at necropsy in African children dying from respiratory illnesses : a descriptive necropsy study |